Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy

Background: Diabetes mellitus causes neurodegeneration of retina before clinical symptoms and signs of diabetic retinopathy (DR), which may result in permanent visual loss. Hence, through neurodegenerative changes, we can predict and prevent DR well in advance. Aims and Objectives: To assess the neu...

Full description

Bibliographic Details
Main Authors: Sankha Subhra Chaudhuri, Asim Kumar Dey, Subhasis Jana, Mousumi Bandyopadhyay, Nabamita Chaudhury, Sukanta Sen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:TNOA Journal of Ophthalmic Science and Research
Subjects:
Online Access:http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2019;volume=57;issue=4;spage=294;epage=298;aulast=Chaudhuri
_version_ 1818974166506799104
author Sankha Subhra Chaudhuri
Asim Kumar Dey
Subhasis Jana
Mousumi Bandyopadhyay
Nabamita Chaudhury
Sukanta Sen
author_facet Sankha Subhra Chaudhuri
Asim Kumar Dey
Subhasis Jana
Mousumi Bandyopadhyay
Nabamita Chaudhury
Sukanta Sen
author_sort Sankha Subhra Chaudhuri
collection DOAJ
description Background: Diabetes mellitus causes neurodegeneration of retina before clinical symptoms and signs of diabetic retinopathy (DR), which may result in permanent visual loss. Hence, through neurodegenerative changes, we can predict and prevent DR well in advance. Aims and Objectives: To assess the neurodegenerative ocular morbidities among patients with diabetes before DR. Materials and Methods: This study included diabetic patients above the age of 40 years who have attended outpatient department of ophthalmology and diabetic clinic under the department of internal medicine in a tertiary care hospital in West Bengal and their age- and sex-matched control group from June 2017 to May 2018. All patients had gone through proper history taking, refraction, intraocular pressure measurement, external ocular examination, slit-lamp biomicroscopy, 90D examination, indirect ophthalmoscopy, and visual evoked potential (VEP). Results: The mean age of cases and controls was 56.87 and 57.29 years, respectively. Male and female percentage of cases and controls were 52.78 and 47.22 and 55.49 and 44.51, respectively. The percentage of Hindu and Muslim patients of cases and controls were 53.89 and 46.11 and 56.1 and 43.9, respectively. The mean P100 latency of the right and left eyes of cases was 108.61 and 107.63, whereas those of controls were 101.03 and 106.35, respectively. The mean P100 amplitude of the right and left eyes of cases was 5.68 and 5.69, whereas those of controls was 6.76 and 6.77, respectively. With respect to duration of diabetes, the mean P100 latency of the right and left eyes for <1 year, 1–2 years, and >2 years was 106.41 and 104.88, 112.19 and 112.15, and 108.38 and 107.31, respectively. With respect to duration of diabetes, the mean P100 amplitude of the right and left eyes for <1 year, 1–2 years, and 2 years was 5.42 and 5.68, 5.76 and 5.52, and 5.83 and 5.79, respectively. Conclusion: Our study shows that VEP changes occur in diabetes patients before the appearance of microaneurysm.
first_indexed 2024-12-20T15:35:44Z
format Article
id doaj.art-afabe05edd1e4068861bd1d90e6b0df7
institution Directory Open Access Journal
issn 2589-4528
2589-4536
language English
last_indexed 2024-12-20T15:35:44Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series TNOA Journal of Ophthalmic Science and Research
spelling doaj.art-afabe05edd1e4068861bd1d90e6b0df72022-12-21T19:35:26ZengWolters Kluwer Medknow PublicationsTNOA Journal of Ophthalmic Science and Research2589-45282589-45362019-01-0157429429810.4103/tjosr.tjosr_83_19Evaluation of visual evoked potential as a predictive marker for diabetic neuropathySankha Subhra ChaudhuriAsim Kumar DeySubhasis JanaMousumi BandyopadhyayNabamita ChaudhurySukanta SenBackground: Diabetes mellitus causes neurodegeneration of retina before clinical symptoms and signs of diabetic retinopathy (DR), which may result in permanent visual loss. Hence, through neurodegenerative changes, we can predict and prevent DR well in advance. Aims and Objectives: To assess the neurodegenerative ocular morbidities among patients with diabetes before DR. Materials and Methods: This study included diabetic patients above the age of 40 years who have attended outpatient department of ophthalmology and diabetic clinic under the department of internal medicine in a tertiary care hospital in West Bengal and their age- and sex-matched control group from June 2017 to May 2018. All patients had gone through proper history taking, refraction, intraocular pressure measurement, external ocular examination, slit-lamp biomicroscopy, 90D examination, indirect ophthalmoscopy, and visual evoked potential (VEP). Results: The mean age of cases and controls was 56.87 and 57.29 years, respectively. Male and female percentage of cases and controls were 52.78 and 47.22 and 55.49 and 44.51, respectively. The percentage of Hindu and Muslim patients of cases and controls were 53.89 and 46.11 and 56.1 and 43.9, respectively. The mean P100 latency of the right and left eyes of cases was 108.61 and 107.63, whereas those of controls were 101.03 and 106.35, respectively. The mean P100 amplitude of the right and left eyes of cases was 5.68 and 5.69, whereas those of controls was 6.76 and 6.77, respectively. With respect to duration of diabetes, the mean P100 latency of the right and left eyes for <1 year, 1–2 years, and >2 years was 106.41 and 104.88, 112.19 and 112.15, and 108.38 and 107.31, respectively. With respect to duration of diabetes, the mean P100 amplitude of the right and left eyes for <1 year, 1–2 years, and 2 years was 5.42 and 5.68, 5.76 and 5.52, and 5.83 and 5.79, respectively. Conclusion: Our study shows that VEP changes occur in diabetes patients before the appearance of microaneurysm.http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2019;volume=57;issue=4;spage=294;epage=298;aulast=Chaudhuridiabetes mellitusdiabetic retinopathyneurodegenerationvisual evoked potential
spellingShingle Sankha Subhra Chaudhuri
Asim Kumar Dey
Subhasis Jana
Mousumi Bandyopadhyay
Nabamita Chaudhury
Sukanta Sen
Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
TNOA Journal of Ophthalmic Science and Research
diabetes mellitus
diabetic retinopathy
neurodegeneration
visual evoked potential
title Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
title_full Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
title_fullStr Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
title_full_unstemmed Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
title_short Evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
title_sort evaluation of visual evoked potential as a predictive marker for diabetic neuropathy
topic diabetes mellitus
diabetic retinopathy
neurodegeneration
visual evoked potential
url http://www.tnoajosr.com/article.asp?issn=2589-4528;year=2019;volume=57;issue=4;spage=294;epage=298;aulast=Chaudhuri
work_keys_str_mv AT sankhasubhrachaudhuri evaluationofvisualevokedpotentialasapredictivemarkerfordiabeticneuropathy
AT asimkumardey evaluationofvisualevokedpotentialasapredictivemarkerfordiabeticneuropathy
AT subhasisjana evaluationofvisualevokedpotentialasapredictivemarkerfordiabeticneuropathy
AT mousumibandyopadhyay evaluationofvisualevokedpotentialasapredictivemarkerfordiabeticneuropathy
AT nabamitachaudhury evaluationofvisualevokedpotentialasapredictivemarkerfordiabeticneuropathy
AT sukantasen evaluationofvisualevokedpotentialasapredictivemarkerfordiabeticneuropathy